カテゴリ： 世界, 医療/バイオ, Market Monitor Global

子宮内避妊具（IUCD）のグローバル市場展望 2023年-2029年：非ホルモン、ホルモン、不活性

■ 英語タイトル：Intrauterine Contraceptive Devices (IUCD) Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY7752）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY7752
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：78
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[子宮内避妊具（IUCD）のグローバル市場展望 2023年-2029年：非ホルモン、ホルモン、不活性]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の子宮内避妊具（IUCD）市場規模と予測を収録しています。・世界の子宮内避妊具（IUCD）市場：売上、2018年-2023年、2024年-2029年
・世界の子宮内避妊具（IUCD）市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の子宮内避妊具（IUCD）市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「非ホルモン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

子宮内避妊具（IUCD）のグローバル主要企業は、Bayer Healthcare AG、 Teva Pharmaceutical Industries Ltd、 Actavis PLC、 Medicines360、 Trimedic Supply Network Ltd、 Medisafe Distribution Inc、 Pace Pharmaceuticals Inc、 DKT International、 Melbea AG、 Pregna International Limited、 Ocon Medical Ltd、 SMB Corporation、 Mona Lisa N.Vなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、子宮内避妊具（IUCD）のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の子宮内避妊具（IUCD）市場：タイプ別、2018年-2023年、2024年-2029年
世界の子宮内避妊具（IUCD）市場：タイプ別市場シェア、2022年
・非ホルモン、ホルモン、不活性

世界の子宮内避妊具（IUCD）市場：用途別、2018年-2023年、2024年-2029年
世界の子宮内避妊具（IUCD）市場：用途別市場シェア、2022年
・T形、V形、その他

世界の子宮内避妊具（IUCD）市場：地域・国別、2018年-2023年、2024年-2029年
世界の子宮内避妊具（IUCD）市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における子宮内避妊具（IUCD）のグローバル売上、2018年-2023年
・主要企業における子宮内避妊具（IUCD）のグローバル売上シェア、2022年
・主要企業における子宮内避妊具（IUCD）のグローバル販売量、2018年-2023年
・主要企業における子宮内避妊具（IUCD）のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Bayer Healthcare AG、 Teva Pharmaceutical Industries Ltd、 Actavis PLC、 Medicines360、 Trimedic Supply Network Ltd、 Medisafe Distribution Inc、 Pace Pharmaceuticals Inc、 DKT International、 Melbea AG、 Pregna International Limited、 Ocon Medical Ltd、 SMB Corporation、 Mona Lisa N.V

*************************************************************

・調査・分析レポートの概要
子宮内避妊具（IUCD）市場の定義
市場セグメント
世界の子宮内避妊具（IUCD）市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の子宮内避妊具（IUCD）市場規模
世界の子宮内避妊具（IUCD）市場規模：2022年 VS 2029年
世界の子宮内避妊具（IUCD）市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの子宮内避妊具（IUCD）の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の子宮内避妊具（IUCD）製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：非ホルモン、ホルモン、不活性
子宮内避妊具（IUCD）のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：T形、V形、その他
子宮内避妊具（IUCD）の用途別グローバル売上・予測

・地域別市場分析
地域別子宮内避妊具（IUCD）市場規模 2022年と2029年
地域別子宮内避妊具（IUCD）売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Bayer Healthcare AG、 Teva Pharmaceutical Industries Ltd、 Actavis PLC、 Medicines360、 Trimedic Supply Network Ltd、 Medisafe Distribution Inc、 Pace Pharmaceuticals Inc、 DKT International、 Melbea AG、 Pregna International Limited、 Ocon Medical Ltd、 SMB Corporation、 Mona Lisa N.V
...

Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman’s uterus to prevent pregnancy. These devices are highly effective, economical, and safe birth control devices. IUDs are considered 99% safe in preventing pregnancy. The contraceptive effect of IUDs is attributable to the localized inflammation that occurs after insertion. The inflammatory reaction in the uterus produces substances that are poisonous for sperms. This affects fertilization. Intrauterine devices can be used immediately after delivery, as they do not affect breastfeeding. These can also be used after abortion. IUDs provide several advantages. They prevent pregnancy for a long time; reduce the chances of ectopic pregnancy; and do not cause discomfort during sex. Once an IUD is removed, the user can quickly return to fertility.

Two types of intrauterine devices available in the U.S. are copper-releasing IUDs and progesterone-releasing IUDs. Copper-releasing IUDs function by releasing copper that is wrapped around the base. The released copper initiates inflammatory reaction in the uterus, which prevents fertilization of the egg. Copper-releasing IUDs are approved for use up to 10 years. Progesterone-releasing IUDs release progestin, which acts by thickening the cervical mucus and creating a barrier to sperms. It also renders the uterus lining unreceptive to implantation of the egg.
This report aims to provide a comprehensive presentation of the global market for Intrauterine Contraceptive Devices (IUCD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intrauterine Contraceptive Devices (IUCD). This report contains market size and forecasts of Intrauterine Contraceptive Devices (IUCD) in global, including the following market information:
Global Intrauterine Contraceptive Devices (IUCD) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Intrauterine Contraceptive Devices (IUCD) Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Intrauterine Contraceptive Devices (IUCD) companies in 2022 (%)
The global Intrauterine Contraceptive Devices (IUCD) market was valued at US$ 3279 million in 2022 and is projected to reach US$ 3793.9 million by 2029, at a CAGR of 2.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Non-hormonal Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Intrauterine Contraceptive Devices (IUCD) include Bayer Healthcare AG, Teva Pharmaceutical Industries Ltd, Actavis PLC, Medicines360, Trimedic Supply Network Ltd, Medisafe Distribution Inc, Pace Pharmaceuticals Inc, DKT International and Melbea AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intrauterine Contraceptive Devices (IUCD) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intrauterine Contraceptive Devices (IUCD) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Intrauterine Contraceptive Devices (IUCD) Market Segment Percentages, by Type, 2022 (%)
Non-hormonal
Hormonal
Inert
Global Intrauterine Contraceptive Devices (IUCD) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Intrauterine Contraceptive Devices (IUCD) Market Segment Percentages, by Application, 2022 (%)
T Shapes
V Shapes
Others
Global Intrauterine Contraceptive Devices (IUCD) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Intrauterine Contraceptive Devices (IUCD) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intrauterine Contraceptive Devices (IUCD) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Intrauterine Contraceptive Devices (IUCD) revenues share in global market, 2022 (%)
Key companies Intrauterine Contraceptive Devices (IUCD) sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Intrauterine Contraceptive Devices (IUCD) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer Healthcare AG
Teva Pharmaceutical Industries Ltd
Actavis PLC
Medicines360
Trimedic Supply Network Ltd
Medisafe Distribution Inc
Pace Pharmaceuticals Inc
DKT International
Melbea AG
Pregna International Limited
Ocon Medical Ltd
SMB Corporation
Mona Lisa N.V
Outline of Major Chapters:
Chapter 1: Introduces the definition of Intrauterine Contraceptive Devices (IUCD), market overview.
Chapter 2: Global Intrauterine Contraceptive Devices (IUCD) market size in revenue and volume.
Chapter 3: Detailed analysis of Intrauterine Contraceptive Devices (IUCD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intrauterine Contraceptive Devices (IUCD) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Intrauterine Contraceptive Devices (IUCD) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Intrauterine Contraceptive Devices (IUCD) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Intrauterine Contraceptive Devices (IUCD) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Intrauterine Contraceptive Devices (IUCD) Overall Market Size
2.1 Global Intrauterine Contraceptive Devices (IUCD) Market Size: 2022 VS 2029
2.2 Global Intrauterine Contraceptive Devices (IUCD) Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Intrauterine Contraceptive Devices (IUCD) Sales: 2018-2029
3 Company Landscape
3.1 Top Intrauterine Contraceptive Devices (IUCD) Players in Global Market
3.2 Top Global Intrauterine Contraceptive Devices (IUCD) Companies Ranked by Revenue
3.3 Global Intrauterine Contraceptive Devices (IUCD) Revenue by Companies
3.4 Global Intrauterine Contraceptive Devices (IUCD) Sales by Companies
3.5 Global Intrauterine Contraceptive Devices (IUCD) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Intrauterine Contraceptive Devices (IUCD) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Intrauterine Contraceptive Devices (IUCD) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Intrauterine Contraceptive Devices (IUCD) Players in Global Market
3.8.1 List of Global Tier 1 Intrauterine Contraceptive Devices (IUCD) Companies
3.8.2 List of Global Tier 2 and Tier 3 Intrauterine Contraceptive Devices (IUCD) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Intrauterine Contraceptive Devices (IUCD) Market Size Markets, 2022 & 2029
4.1.2 Non-hormonal
4.1.3 Hormonal
4.1.4 Inert
4.2 By Type – Global Intrauterine Contraceptive Devices (IUCD) Revenue & Forecasts
4.2.1 By Type – Global Intrauterine Contraceptive Devices (IUCD) Revenue, 2018-2023
4.2.2 By Type – Global Intrauterine Contraceptive Devices (IUCD) Revenue, 2024-2029
4.2.3 By Type – Global Intrauterine Contraceptive Devices (IUCD) Revenue Market Share, 2018-2029
4.3 By Type – Global Intrauterine Contraceptive Devices (IUCD) Sales & Forecasts
4.3.1 By Type – Global Intrauterine Contraceptive Devices (IUCD) Sales, 2018-2023
4.3.2 By Type – Global Intrauterine Contraceptive Devices (IUCD) Sales, 2024-2029
4.3.3 By Type – Global Intrauterine Contraceptive Devices (IUCD) Sales Market Share, 2018-2029
4.4 By Type – Global Intrauterine Contraceptive Devices (IUCD) Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Intrauterine Contraceptive Devices (IUCD) Market Size, 2022 & 2029
5.1.2 T Shapes
5.1.3 V Shapes
5.1.4 Others
5.2 By Application – Global Intrauterine Contraceptive Devices (IUCD) Revenue & Forecasts
5.2.1 By Application – Global Intrauterine Contraceptive Devices (IUCD) Revenue, 2018-2023
5.2.2 By Application – Global Intrauterine Contraceptive Devices (IUCD) Revenue, 2024-2029
5.2.3 By Application – Global Intrauterine Contraceptive Devices (IUCD) Revenue Market Share, 2018-2029
5.3 By Application – Global Intrauterine Contraceptive Devices (IUCD) Sales & Forecasts
5.3.1 By Application – Global Intrauterine Contraceptive Devices (IUCD) Sales, 2018-2023
5.3.2 By Application – Global Intrauterine Contraceptive Devices (IUCD) Sales, 2024-2029
5.3.3 By Application – Global Intrauterine Contraceptive Devices (IUCD) Sales Market Share, 2018-2029
5.4 By Application – Global Intrauterine Contraceptive Devices (IUCD) Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Intrauterine Contraceptive Devices (IUCD) Market Size, 2022 & 2029
6.2 By Region – Global Intrauterine Contraceptive Devices (IUCD) Revenue & Forecasts
6.2.1 By Region – Global Intrauterine Contraceptive Devices (IUCD) Revenue, 2018-2023
6.2.2 By Region – Global Intrauterine Contraceptive Devices (IUCD) Revenue, 2024-2029
6.2.3 By Region – Global Intrauterine Contraceptive Devices (IUCD) Revenue Market Share, 2018-2029
6.3 By Region – Global Intrauterine Contraceptive Devices (IUCD) Sales & Forecasts
6.3.1 By Region – Global Intrauterine Contraceptive Devices (IUCD) Sales, 2018-2023
6.3.2 By Region – Global Intrauterine Contraceptive Devices (IUCD) Sales, 2024-2029
6.3.3 By Region – Global Intrauterine Contraceptive Devices (IUCD) Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Intrauterine Contraceptive Devices (IUCD) Revenue, 2018-2029
6.4.2 By Country – North America Intrauterine Contraceptive Devices (IUCD) Sales, 2018-2029
6.4.3 US Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.4.4 Canada Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.4.5 Mexico Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Intrauterine Contraceptive Devices (IUCD) Revenue, 2018-2029
6.5.2 By Country – Europe Intrauterine Contraceptive Devices (IUCD) Sales, 2018-2029
6.5.3 Germany Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.5.4 France Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.5.5 U.K. Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.5.6 Italy Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.5.7 Russia Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.5.8 Nordic Countries Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.5.9 Benelux Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Intrauterine Contraceptive Devices (IUCD) Revenue, 2018-2029
6.6.2 By Region – Asia Intrauterine Contraceptive Devices (IUCD) Sales, 2018-2029
6.6.3 China Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.6.4 Japan Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.6.5 South Korea Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.6.6 Southeast Asia Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.6.7 India Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Intrauterine Contraceptive Devices (IUCD) Revenue, 2018-2029
6.7.2 By Country – South America Intrauterine Contraceptive Devices (IUCD) Sales, 2018-2029
6.7.3 Brazil Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.7.4 Argentina Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Intrauterine Contraceptive Devices (IUCD) Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Intrauterine Contraceptive Devices (IUCD) Sales, 2018-2029
6.8.3 Turkey Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.8.4 Israel Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.8.5 Saudi Arabia Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
6.8.6 UAE Intrauterine Contraceptive Devices (IUCD) Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bayer Healthcare AG
7.1.1 Bayer Healthcare AG Company Summary
7.1.2 Bayer Healthcare AG Business Overview
7.1.3 Bayer Healthcare AG Intrauterine Contraceptive Devices (IUCD) Major Product Offerings
7.1.4 Bayer Healthcare AG Intrauterine Contraceptive Devices (IUCD) Sales and Revenue in Global (2018-2023)
7.1.5 Bayer Healthcare AG Key News & Latest Developments
7.2 Teva Pharmaceutical Industries Ltd
7.2.1 Teva Pharmaceutical Industries Ltd Company Summary
7.2.2 Teva Pharmaceutical Industries Ltd Business Overview
7.2.3 Teva Pharmaceutical Industries Ltd Intrauterine Contraceptive Devices (IUCD) Major Product Offerings
7.2.4 Teva Pharmaceutical Industries Ltd Intrauterine Contraceptive Devices (IUCD) Sales and Revenue in Global (2018-2023)
7.2.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments
7.3 Actavis PLC
7.3.1 Actavis PLC Company Summary
7.3.2 Actavis PLC Business Overview
7.3.3 Actavis PLC Intrauterine Contraceptive Devices (IUCD) Major Product Offerings
7.3.4 Actavis PLC Intrauterine Contraceptive Devices (IUCD) Sales and Revenue in Global (2018-2023)
7.3.5 Actavis PLC Key News & Latest Developments
7.4 Medicines360
7.4.1 Medicines360 Company Summary
7.4.2 Medicines360 Business Overview
7.4.3 Medicines360 Intrauterine Contraceptive Devices (IUCD) Major Product Offerings
7.4.4 Medicines360 Intrauterine Contraceptive Devices (IUCD) Sales and Revenue in Global (2018-2023)
7.4.5 Medicines360 Key News & Latest Developments
7.5 Trimedic Supply Network Ltd
7.5.1 Trimedic Supply Network Ltd Company Summary
7.5.2 Trimedic Supply Network Ltd Business Overview
7.5.3 Trimedic Supply Network Ltd Intrauterine Contraceptive Devices (IUCD) Major Product Offerings
7.5.4 Trimedic Supply Network Ltd Intrauterine Contraceptive Devices (IUCD) Sales and Revenue in Global (2018-2023)
7.5.5 Trimedic Supply Network Ltd Key News & Latest Developments
7.6 Medisafe Distribution Inc
7.6.1 Medisafe Distribution Inc Company Summary
7.6.2 Medisafe Distribution Inc Business Overview
7.6.3 Medisafe Distribution Inc Intrauterine Contraceptive Devices (IUCD) Major Product Offerings
7.6.4 Medisafe Distribution Inc Intrauterine Contraceptive Devices (IUCD) Sales and Revenue in Global (2018-2023)
7.6.5 Medisafe Distribution Inc Key News & Latest Developments
7.7 Pace Pharmaceuticals Inc
7.7.1 Pace Pharmaceuticals Inc Company Summary
7.7.2 Pace Pharmaceuticals Inc Business Overview
7.7.3 Pace Pharmaceuticals Inc Intrauterine Contraceptive Devices (IUCD) Major Product Offerings
7.7.4 Pace Pharmaceuticals Inc Intrauterine Contraceptive Devices (IUCD) Sales and Revenue in Global (2018-2023)
7.7.5 Pace Pharmaceuticals Inc Key News & Latest Developments
7.8 DKT International
7.8.1 DKT International Company Summary
7.8.2 DKT International Business Overview
7.8.3 DKT International Intrauterine Contraceptive Devices (IUCD) Major Product Offerings
7.8.4 DKT International Intrauterine Contraceptive Devices (IUCD) Sales and Revenue in Global (2018-2023)
7.8.5 DKT International Key News & Latest Developments
7.9 Melbea AG
7.9.1 Melbea AG Company Summary
7.9.2 Melbea AG Business Overview
7.9.3 Melbea AG Intrauterine Contraceptive Devices (IUCD) Major Product Offerings
7.9.4 Melbea AG Intrauterine Contraceptive Devices (IUCD) Sales and Revenue in Global (2018-2023)
7.9.5 Melbea AG Key News & Latest Developments
7.10 Pregna International Limited
7.10.1 Pregna International Limited Company Summary
7.10.2 Pregna International Limited Business Overview
7.10.3 Pregna International Limited Intrauterine Contraceptive Devices (IUCD) Major Product Offerings
7.10.4 Pregna International Limited Intrauterine Contraceptive Devices (IUCD) Sales and Revenue in Global (2018-2023)
7.10.5 Pregna International Limited Key News & Latest Developments
7.11 Ocon Medical Ltd
7.11.1 Ocon Medical Ltd Company Summary
7.11.2 Ocon Medical Ltd Intrauterine Contraceptive Devices (IUCD) Business Overview
7.11.3 Ocon Medical Ltd Intrauterine Contraceptive Devices (IUCD) Major Product Offerings
7.11.4 Ocon Medical Ltd Intrauterine Contraceptive Devices (IUCD) Sales and Revenue in Global (2018-2023)
7.11.5 Ocon Medical Ltd Key News & Latest Developments
7.12 SMB Corporation
7.12.1 SMB Corporation Company Summary
7.12.2 SMB Corporation Intrauterine Contraceptive Devices (IUCD) Business Overview
7.12.3 SMB Corporation Intrauterine Contraceptive Devices (IUCD) Major Product Offerings
7.12.4 SMB Corporation Intrauterine Contraceptive Devices (IUCD) Sales and Revenue in Global (2018-2023)
7.12.5 SMB Corporation Key News & Latest Developments
7.13 Mona Lisa N.V
7.13.1 Mona Lisa N.V Company Summary
7.13.2 Mona Lisa N.V Intrauterine Contraceptive Devices (IUCD) Business Overview
7.13.3 Mona Lisa N.V Intrauterine Contraceptive Devices (IUCD) Major Product Offerings
7.13.4 Mona Lisa N.V Intrauterine Contraceptive Devices (IUCD) Sales and Revenue in Global (2018-2023)
7.13.5 Mona Lisa N.V Key News & Latest Developments
8 Global Intrauterine Contraceptive Devices (IUCD) Production Capacity, Analysis
8.1 Global Intrauterine Contraceptive Devices (IUCD) Production Capacity, 2018-2029
8.2 Intrauterine Contraceptive Devices (IUCD) Production Capacity of Key Manufacturers in Global Market
8.3 Global Intrauterine Contraceptive Devices (IUCD) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Intrauterine Contraceptive Devices (IUCD) Supply Chain Analysis
10.1 Intrauterine Contraceptive Devices (IUCD) Industry Value Chain
10.2 Intrauterine Contraceptive Devices (IUCD) Upstream Market
10.3 Intrauterine Contraceptive Devices (IUCD) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Intrauterine Contraceptive Devices (IUCD) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 動物用医薬品調剤のグローバル市場展望 2023年-2029年：抗感染症薬、ホルモン＆代替薬、抗炎症薬、その他
  • 内因性ペプチド物質のグローバル市場展望 2023年-2029年：神経ペプチド、ホルモン、サイトカイン、ペプチドホルモン、生理活性ペプチド
  • クローズドシステム転送デバイス（CSTD）のグローバル市場展望 2023年-2029年：クローズドシステム開発用、空気清浄装置用
  • 自動車用SiCデバイス（ディスクリート）のグローバル市場展望 2023年-2029年：SiC MOSFETディスクリート、SiCダイオードディスクリート（SiC SBD）、その他
  • 長時間作用型可逆的避妊薬（LARC）のグローバル市場展望 2023年-2029年：子宮内避妊器具（IUC）、皮下インプラント
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY7752 )"子宮内避妊具（IUCD）のグローバル市場展望 2023年-2029年：非ホルモン、ホルモン、不活性" (英文：Intrauterine Contraceptive Devices (IUCD) Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。